Nuvama Starts HFCL Coverage With Buy Recommendation Nuvama has initiated coverage of HFCL with a Buy rating, marking the beginning of its formal research coverage of the...
Nuvama has initiated coverage of HFCL with a Buy rating, marking the beginning of its formal research coverage of the company.
The announcement identifies Nuvama as the research firm and HFCL as the company under review. It does not provide additional details on the reasoning behind the rating, a price target or expected financial outcomes.
For investors and market participants, the key disclosed development is Nuvama’s new coverage and its positive recommendation. Further assessment of the call would require the full research note or additional details from Nuvama.
Based on the available information, no other business or market implications can be established.
Ramayana Day 5 Box Office: Film Earns ₹107 Crore on Monday Ranbir Kapoor and Yash-starrer Ramayana has reportedly delivered a ₹107 crore net collection on its f...
Scientists discover a surprising link between acorns and lyme disease
Nvidia Investigates Reports Involving Alice Huang and CEO Jensen Huang Nvidia is investigating reports concerning chief executive Jensen Huang and Alice Huang, who previ...
